Abstract
In recent years, experimental animal studies have demonstrated that no modulated high frequency alternating currents (HFAC) produce a rapid and reversible peripheral nerve block without causing damage to the nerve [1]. Clinical studies to date have investigated transcutaneous stimulation protocols leading to an increase in somatosensory thresholds [2]. Pain improvements have been demonstrated in humans with 10 and 20 kHz applications with implanted electrodes [3]. The objective of this study was to determine the effect on pressure pain threshold (PPT) of percutaneous ultrasound-guided stimulation of the median nerve with alternating currents of 30 kHz.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
